CN1077571C - 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺 - Google Patents

用于抑制细胞增殖的取代的双吲哚基马来酰亚胺 Download PDF

Info

Publication number
CN1077571C
CN1077571C CN97196783A CN97196783A CN1077571C CN 1077571 C CN1077571 C CN 1077571C CN 97196783 A CN97196783 A CN 97196783A CN 97196783 A CN97196783 A CN 97196783A CN 1077571 C CN1077571 C CN 1077571C
Authority
CN
China
Prior art keywords
methyl
compound
indole
pyrroles
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97196783A
Other languages
English (en)
Chinese (zh)
Other versions
CN1226248A (zh
Inventor
厄瓦什·H·德欣格拉
唐娜·M·赫因
丹尼斯·D·基思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1226248A publication Critical patent/CN1226248A/zh
Application granted granted Critical
Publication of CN1077571C publication Critical patent/CN1077571C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN97196783A 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺 Expired - Fee Related CN1077571C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2207896P 1996-07-29 1996-07-29
US60/022,078 1996-07-29
US4849697P 1997-06-03 1997-06-03
US60/048,496 1997-06-03

Publications (2)

Publication Number Publication Date
CN1226248A CN1226248A (zh) 1999-08-18
CN1077571C true CN1077571C (zh) 2002-01-09

Family

ID=26695475

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97196783A Expired - Fee Related CN1077571C (zh) 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺

Country Status (20)

Country Link
US (1) US6228877B1 (cg-RX-API-DMAC10.html)
EP (1) EP0915870B1 (cg-RX-API-DMAC10.html)
JP (1) JP2000516588A (cg-RX-API-DMAC10.html)
KR (1) KR20000029640A (cg-RX-API-DMAC10.html)
CN (1) CN1077571C (cg-RX-API-DMAC10.html)
AR (1) AR007969A1 (cg-RX-API-DMAC10.html)
AT (1) ATE224889T1 (cg-RX-API-DMAC10.html)
AU (1) AU740011B2 (cg-RX-API-DMAC10.html)
BR (1) BR9711607A (cg-RX-API-DMAC10.html)
CA (1) CA2262089A1 (cg-RX-API-DMAC10.html)
CO (1) CO4900054A1 (cg-RX-API-DMAC10.html)
DE (1) DE69715870T2 (cg-RX-API-DMAC10.html)
DK (1) DK0915870T3 (cg-RX-API-DMAC10.html)
ES (1) ES2183163T3 (cg-RX-API-DMAC10.html)
HR (1) HRP970415A2 (cg-RX-API-DMAC10.html)
MA (1) MA24354A1 (cg-RX-API-DMAC10.html)
PE (1) PE91598A1 (cg-RX-API-DMAC10.html)
PT (1) PT915870E (cg-RX-API-DMAC10.html)
TR (1) TR199900186T2 (cg-RX-API-DMAC10.html)
WO (1) WO1998004551A1 (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064279B1 (en) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
EP1224181B1 (en) * 1999-10-12 2003-12-03 F. Hoffmann-La Roche Ag Substituted pyrroles as antiproliferative agents for the treatment of cancer
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
MXPA04004026A (es) * 2001-10-29 2004-07-08 Nektar Therapeutics Al Corp Conjugados polimericos de inhibidores de la proteina quinasa c.
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
RS51826B (sr) 2005-02-09 2012-02-29 Arqule Inc. Maleimid derivati, farmaceutske kompozicije i postupak lečenja kancera
JP2010513386A (ja) * 2006-12-19 2010-04-30 ノバルティス アーゲー キナーゼ阻害剤としてのインドリルマレイミド誘導体
AU2008268613A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
EP2392574B1 (en) 2007-06-22 2013-12-18 ArQule, Inc. Indolyl pyrrolidines for the treatment of cancer
CA2690799C (en) * 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN105777751B (zh) * 2016-04-26 2018-12-11 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
CN107973785B (zh) * 2017-11-27 2019-12-31 浙江工业大学上虞研究院有限公司 一种用于检测银离子的荧光探针及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
JPH0539289A (ja) 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
JPH07504673A (ja) 1992-03-20 1995-05-25 ザ・ウエルカム・ファウンデーション・リミテッド 抗ウイルス活性を有するインドール誘導体
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
MA24354A1 (fr) 1998-07-01
PT915870E (pt) 2003-01-31
CN1226248A (zh) 1999-08-18
JP2000516588A (ja) 2000-12-12
DE69715870D1 (de) 2002-10-31
HRP970415A2 (en) 1998-08-31
PE91598A1 (es) 1998-12-24
EP0915870B1 (en) 2002-09-25
US6228877B1 (en) 2001-05-08
EP0915870A1 (en) 1999-05-19
AR007969A1 (es) 1999-11-24
DE69715870T2 (de) 2003-06-18
BR9711607A (pt) 1999-08-24
DK0915870T3 (da) 2003-02-03
ATE224889T1 (de) 2002-10-15
AU740011B2 (en) 2001-10-25
WO1998004551A1 (en) 1998-02-05
CA2262089A1 (en) 1998-02-05
KR20000029640A (ko) 2000-05-25
ES2183163T3 (es) 2003-03-16
TR199900186T2 (xx) 1999-03-22
CO4900054A1 (es) 2000-03-27
AU4296397A (en) 1998-02-20

Similar Documents

Publication Publication Date Title
CN1077571C (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1148183C (zh) 具有抗肿瘤作用的吲哚基-3-乙醛酸衍生物
CN1231478C (zh) 光学活性的哌啶中间体的制备方法和该中间体
CN1151167C (zh) 嘌呤衍生物
CN1196687C (zh) Impdh酶抑制剂
CN1053190C (zh) 新的喹喔啉二酮衍生物、其制备方法和作为药物的应用
CN1309385C (zh) 作为5－羟色胺－6配体的吲哚基烷基胺衍生物
CN1976919A (zh) 作为erk蛋白激酶抑制剂的吡咯化合物、它们的合成和中间体
CN1151149C (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1639159A (zh) N－氨基乙酰基－吡咯烷－2－腈和它们作为ddp－iv抑制剂的用途
CN1349524A (zh) 血管紧张肽原酶抑制剂
CN1437596A (zh) 苯基哌嗪基衍生物
CN1058404A (zh) 苯并咪唑的新型衍生物、其制备及其药物用途
CN1934083A (zh) 作为肾素抑制剂用于治疗高血压的5－氨基－4－羟基－7－(1h－吲哚基甲基)－8－甲基壬酰胺衍生物
CN1675193A (zh) 1－甲基－2－(4－脒基苯基氨甲基)－苯并咪唑－5－基－羧酸－(n－2－吡啶基－n－2－羟基羰基乙基－酰胺的新颖前药，其制法及其作为药物制剂的用途
CN1094930C (zh) 喹喔啉及其制备方法与应用
CN1434819A (zh) 4－苯基－1－哌嗪基、－哌啶基和－四氢吡啶基衍生物
CN1125446A (zh) [1，2，4]三唑并[4，3-α]喹喔啉化合物，它们的制备及其应用
CN1158610A (zh) 可用于治疗的喹喔啉衍生物
CN1900076A (zh) 四氢原小檗碱类化合物及其制备方法和用途
CN1133641C (zh) 一种含有3'叠氮胸苷的硫代磷酰氨基酸酯化合物及其制备方法
CN1055472C (zh) 噁唑并喹啉酮衍生物,它们的制备及其在治疗上的应用
CN1604892A (zh) D－脯氨酸的前药
CN1057840A (zh) 新的抗病毒四氢咪唑并[1，4]苯并二氮杂-2-(硫)酮
CN1029971C (zh) 制备抗病毒的四氢咪唑并[1,4]苯并二氮杂䓬的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee